Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease atrial fibrillation
Comorbidity C0018799|heart disease
Sentences 48
PubMedID- 23465222 Objectives: the aim of this study was to determine whether altered calreticulin expression and distribution contribute to the pathogenesis of atrial fibrillation (af) associated with valvular heart disease (vhd).
PubMedID- 20417758 Efficacy of surgical ablation of atrial fibrillation in patients with rheumatic heart disease.
PubMedID- 22263119 We reportthat results of cox-maze iv procedure for treatment of chronic afib associated with valvular heart disease is 80.7% of success rate at 6months and 3.3% recurrence rate afterwards.
PubMedID- 25742550 The midterm results of radiofrequency ablation and vagal denervation in the surgical treatment of long-standing atrial fibrillation associated with rheumatic heart disease.
PubMedID- 22547769 Aims: the aim of this study was to determine whether altered expression and distribution of calcium- and integrin-binding protein-1 (cib1) is involved in the pathogenesis of different types of patients with atrial fibrillation (af) associated with valvular heart disease (vhd).
PubMedID- 22113757 Background: acute alcohol consumption can cause atrial fibrillation in patients with, and without, heart disease.
PubMedID- 23683253 Introduction: an oral loading dose of propafenone 600 mg is used in our center as in other places around the world for conversion of recent-onset atrial fibrillation (af) in patients without structural heart disease.
PubMedID- 21219558 atrial fibrillation is commonly associated with structural heart disease and is a major cause of significant cardiovascular morbidity and mortality.
PubMedID- 26519209 Inherited structural heart diseases with potential atrial fibrillation occurrence.
PubMedID- 20550616 Catheter ablation of atrial fibrillation in patients with valvular heart disease: long-term follow-up results.
PubMedID- 24755126 Objective: to compare the therapeutic warfarin and aspirin efficacies for treatments of atrial fibrillation (af) complicated with stable coronary heart disease particularly in older chinese patients.
PubMedID- 23095227 Methods and results: we report 5 paroxysmal atrial fibrillation cases without any structural heart disease in which dormant thoracic vein conduction was associated with recurrent atrial tachyarrhythmias.
PubMedID- 22354975 Management of atrial fibrillation in patients with structural heart disease.
PubMedID- 22291468 This agent can be considered as a first-line therapy for atrial fibrillation in patients with structural heart disease who have an ejection fraction >35% and no recent decompensated heart failure.
PubMedID- 23126050 The patient was already known to have liver cirrhosis of ethylic etiology, cardiac decompensation caused by hypertensive heart disease with permanent atrial fibrillation, chronic obstructive pulmonary disease, diabetes mellitus type 2, and cholelithiasis.
PubMedID- 23121003 Backgrounds: atrial fibrillation (af) is commonly associated with structural heart disease (shd) or sinus node dysfunction (snd).
PubMedID- 22108512 Vernakalant: conversion of atrial fibrillation in patients with ischemic heart disease.
PubMedID- 21287469 New procedure for treatment of atrial fibrillation in patients with valvular heart disease.
PubMedID- 20937979 Electropathological substrate of longstanding persistent atrial fibrillation in patients with structural heart disease: epicardial breakthrough.
PubMedID- 26261514 Therefore, we hypothesized that synd4 shedding was also involved in the inflammatory response in atrial fibrillation patients with valvular heart disease.
PubMedID- 24282904 Conclusion: overexpression of nfkappab, icam1, and vcam1 may be involved in the development and maintenance of atrial fibrillation in patients with rheumatic heart disease.
PubMedID- 22469422 Pulmonary vein isolation for the treatment of drug-refractory atrial fibrillation in adults with congenital heart disease.
PubMedID- 21311690 The loss of short-term fractal correlation property that we found in copd subjects is related to the occurrence of several adverse clinical events such as heart failure23,25 and acute myocardial infarction.30 in addition, reduction of alpha-1 was observed before spontaneous onset of atrial fibrillation in patients without structural heart disease27 associated with vulnerability to ventricular tachycardia23,30 and ventricular fibrillation.31 exponent values lower than 0.85 were observed in patients with cardiovascular disease associated with increased mortality rate.28–30 these values are close to those found in our study (alpha-1 = 0.899) in copd patients.
PubMedID- 22056820 atrial fibrillation is commonly associated with structural heart disease, and af itself causes a sequence of complex processes of electrical, contractile, and structural remodeling of the atrial myocardium, which facilitate further af progression.
PubMedID- 24088003 [the use of implantable devices for long-term monitoring of cardiac rhythm after surgical treatment of atrial fibrillation in patients with ischemic heart disease].
PubMedID- 25216788 Introduction: there are few studies comparing the pathology of the remodeled substrate in patients of rheumatic heart disease with atrial fibrillation (af) and normal sinus rhythm (nsr).
PubMedID- 24431682 The indications were valvular heart disease with valve replacement, atrial fibrillation, or thrombus in 60 % patients; chronic deep vein thrombosis (dvt) in 7 % patients; thrombophilia in 9.1 % patients; recurrent pregnancy losses in 18 % patients; and dvt prophylaxis in 5.5 % patients.
PubMedID- 25766663 Early efficacy analysis of biatrial ablation versus left and simplified right atrial ablation for atrial fibrillation treatment in patients with rheumatic heart disease.
PubMedID- 25971370 To investigate the involvement of transforming growth factor-beta1 (tgf-beta1) and tissue inhibitor of metalloproteinase 4 (timp-4) in influencing the severity of atrial fibrosis in rheumatic heart disease (rhd) patients with atrial fibrillation (af).
PubMedID- 25796343 We investigated the relationship between transient receptor potential channel subfamily m6 (trpm6) and atrial fibrosis in rheumatic heart disease patients with atrial fibrillation (af).
PubMedID- 23631185 [atrial fibrillation concomitant with valvular heart disease].
PubMedID- 20413814 [the efficasy of atorvastatin in the case of paroxismal atrial fibrillation in patients with ischemic heart disease].
PubMedID- 19919968 Right to left shunt following radiofrequency catheter ablation of atrial fibrillation in a patient with complex congenital heart disease.
PubMedID- 21911268 The increase in sympathetic nerve density in the atrium facilitates atrial fibrillation in patients with rheumatic heart disease.
PubMedID- 22676979 Conclusions: concomitant bipolar radiofrequency ablation is an effective and safe technique for treating atrial fibrillation in patients with rheumatic heart disease undergoing valve replacement, with promising follow-up results.
PubMedID- 23631186 [management of atrial fibrillation comorbid with coronary heart disease].
PubMedID- 25876726 Results: a total of 17 rhabdomyolysis patients (male 13, mean age (60.4 +/- 15.7) years) were analyzed.four cases had coronary heart disease combined with hypertension, hyperlipaemia, atrial fibrillation, 10 cases had dilated cardiomyopathy combined with coronary heart disease, hyperlipaemia, atrial fibrillation, 8 cases had atrial fibrillation combined with hypertension, coronary heart disease, hyperlipaemia, 1 patient had pulmonary embolism combined with hyperlipaemia, 1 patient had aortic dissection combined with hypertension, 10 hypertension patients were combined with coronary heart disease, hyperlipaemia, atrial fibrillation, aortic dissection and 1 patient with ventricular tachycardia was combined with depression.various degrees of liver and kidney dysfunction, reduced hemoglobin and myoglobinuria were found in all patients.fever was found in 7 cases, relevant neurological signs in 5 cases.
PubMedID- 24422171 Cmultivariate adjusted for age, new york heart association function class, ischaemic heart disease, history of hypertension and atrial fibrillation.
PubMedID- 26056191 Thus, single oral doses of 600 mg propafenone appear also suitable for cardioversion of paroxysmal atrial fibrillation in patients with structural heart disease since beta-blockers are explicitly indicated in the treatment of both coronary artery disease and heart failure.
PubMedID- 21584749 However, in chronic atrial fibrillation patients without structural heart disease, b-type natriuretic peptide levels did not differ between those with and without heart failure symptoms.
PubMedID- 20837368 Novel non-invasive p wave analysis for the prediction of paroxysmal atrial fibrillation recurrences in patients without structural heart disease: a prospective pilot study.
PubMedID- 25151145 Angiotensin ii activates signal transducers and activators of transcription 3 via rac1 in the atrial tissue in permanent atrial fibrillation patients with rheumatic heart disease.
PubMedID- 25146364 Purpose: atrial fibrillation (af) is commonly associated with structural heart disease.
PubMedID- 22203918 Disputable side effects are the risk of atrial fibrillation in patients with intrinsic heart disease and increased bone loss in postmenopausal women [57, 58].
PubMedID- 24557149 Role of masked coronary heart disease in patients with recent-onset atrial fibrillation and troponin elevations.
PubMedID- 21884876 The chads2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the heart and soul study.
PubMedID- 25175091 The majority of studies that aimed to study lone atrial fibrillation excluded patients with structural heart disease, but did not exclude patients with co-existing cardiovascular risk factors such as hypertension or diabetes mellitus.
PubMedID- 24640700 [especially in the hemostatic system in geriatric patients with ischemic heart disease, complicated by persistent atrial fibrillation].

Page: 1